Medicinal Genomics and Courtagen Life Sciences Announce CannMed 2017

Warning message

The subscription service is currently unavailable. Please try again later.

Medicinal Genomics and Courtagen Life Sciences today announced that they will host the 2nd annual CannMed 2017 Personalized Cannabinoid Medicine Conference to be held on April 9-11 in Boston, MA. The conference will focus on the intersection of clinical application, medical research, cannabis-based therapeutics, cannabis safety and production.

Based on the success of last year’s inaugural conference, CannMed 2017 will include several exciting new developments:

  • Conference sessions are extended to two full days.
  • Topics are expanded to cover a wider range of clinical areas including cancer, inflammatory disorders, and neurological disorders, as well as cannabis regulations.
  • CME credits are available for health care professionals through a partnership with The Answer Page.

The conference will open with a dinner reception on Sunday, April 9th, followed by full day programs on Monday, April 10th and Tuesday, April 11th at the Joseph B. Martin Conference...

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 
Region: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.